All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are the most important and recent advances made in AML treatment?

During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the AML Global Portal were delighted to speak to Jeffrey Lancet, Moffitt Cancer Center, Tampa, US. We asked: What are the most important and recent advances made in AML treatment?

Jeffrey Lancet discusses the emergence of novel compounds and how that has shaped the AML treatment landscape. He summarizes the results of his study that examine a new regimen in a high-risk patient population. Jeffrey Lancet concludes by discussing a study that explored new maintenance therapies that aimed to prolong remission.

What are the most important and recent advances made in AML treatment?

Share: